Clearbridge R

Clearbridge

Meituan MB eCW260804

Pacific RadianceW270919

Alibaba MB ePW261005

NKY 59000MBeCW260612

Mary Chia

Vins

Luxking

SIA MB eCW260930

P-Nova Short MSSG-1X USy

9RQR

Clear Street reported a 160% revenue increase in the first nine months of 2025, according to its U.S. IPO filing. This surge comes as the U.S. market anticipates a busy year for new listings, with analysts predicting a strong start to IPO activity in 2026.

Clear Secure

Clear Street reveals revenue surge in US IPO filing as new listings gain momentum

Clearbridge Health Limited raised $1.98 million through the placement of 990 million new ordinary shares at $0.002 each. The funds will be used for working capital, immediate business needs, and to maintain competitiveness. Following the placement, the total issued shares increased from 3.305 billion to 4.295 billion. The placement attracted interest from notable investors, including Asdew Acquisitions and Azure Capital. Additionally, some funds will support the creation of adult immune cellular banking and the proposed acquisition of Elpis Biopharmaceuticals.

Singapore Business Review

Clearbridge Health raises $1.98m from 990 million placement shares

Clearbridge Health Ltd. has announced a transition from quarterly to half-yearly financial reporting, following an unmodified opinion from its independent auditor on FY2024 financial statements. This change aims to comply with Catalist Rules and streamline the reporting process while maintaining disclosure obligations. Clearbridge Health operates in the healthcare sector in Singapore, focusing on services and solutions in the Asian market. Current market cap is €4.36M.

Tip Ranks

Clearbridge Health Transitions to Half-Yearly Financial Reporting

Clearbridge R(9RQR.SG)

Clear Street reveals revenue surge in US IPO filing as new listings gain momentum

Clearbridge Health raises $1.98m from 990 million placement shares

Clearbridge Health Transitions to Half-Yearly Financial Reporting